Home | Services | Products | Support | Useful Documents | Experience | Staff | Opportunities  
 
   
News
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of calcitonin gene-related peptide antagonists for the prevention of migraine
eSYS Development contracted with the Royal Australasian College of Surgeons to assess deep brain stimulation of the thalamus for the treatment of severe refractory epilepsy for MSAC in Australia
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of treatment of hypercholesterolemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinsonís disease
Ross McLeod joins World Health Organization Technical and Scientific Advisory Group on the Development of Target Product Profiles (TPPs) for Snake Antivenom Products
Annual Costs of Feral Deer in Australia
 
 

Latest News  
   
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of calcitonin gene-related peptide antagonists for the prevention of migraine
 



FOPH note the aim of the HTA is to evaluate the effectiveness, safety, costs, cost-effectiveness and budget impact of CGRP antagonists compared to standard of care medications in patients who suffer from episodic and/or chronic migraine. https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/cgrp-antagonists.html

Previous News

Next News